menu
    • menu

    Company profile for OpGen

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes.Our innovative approaches to infectious ...
    OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes.Our innovative approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OpGenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9717 Key West Avenue, Suite 100 Rockville, Maryland 20850
    Telephone
    Telephone
    301.869.9683
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.opgen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/opgen/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/opgen

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
    OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q

    24 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/24/2888166/35690/en/OpGen-Receives-Expected-Nasdaq-Notice-Regarding-Delayed-Form-10-Q.html

    GLOBENEWSWIRE
    24 May 2024
    Share Share
    OpGen Announced 1-for-10 Reverse Stock Split
    OpGen Announced 1-for-10 Reverse Stock Split

    16 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/16/2883250/35690/en/OpGen-Announced-1-for-10-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    16 May 2024
    Share Share
    OpGen Provides Update on Business Operations and Strategic Opportunities
    OpGen Provides Update on Business Operations and Strategic Opportunities

    29 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/29/2871630/35690/en/OpGen-Provides-Update-on-Business-Operations-and-Strategic-Opportunities.html

    GLOBENEWSWIRE
    29 Apr 2024
    Share Share
    OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
    OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K

    23 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/23/2868142/35690/en/OpGen-Receives-Nasdaq-Notice-Regarding-Delayed-Form-10-K.html

    GLOBENEWSWIRE
    23 Apr 2024
    Share Share
    OpGen Announces Acquisition of Preferred Stock by David Lazar
    OpGen Announces Acquisition of Preferred Stock by David Lazar

    25 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/25/2851992/35690/en/OpGen-Announces-Acquisition-of-Preferred-Stock-by-David-Lazar.html

    GLOBENEWSWIRE
    25 Mar 2024
    Share Share
    OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
    OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update

    14 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/14/2780555/35690/en/OpGen-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    14 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search